Miller joins as Chief Business Officer/Chief Operating Officer and brings decades of corporate strategy and business development experience in the biotech and pharmaceutical industries
Cambridge, Massachusetts, March 23, 2022 /PRNewswire/ — Totus Medicines, a drug discovery company that uses innovative chemical biology technologies to develop life-changing covalent therapies for untreatable diseases, today announced the following hires: Laura Miller As the company’s first Chief Business Officer (CBO) / Chief Operating Officer (COO). Miller is the CEO and co-founder of Dr. Neal Dhawanholds a Ph.D. and helps execute the company’s strategy and vision.
Miller joins Totus with over 20 years of business development experience in the biotechnology and pharmaceutical industries. In her new role, she will lead corporate strategic initiatives, oversee operations, and be responsible for developing and transforming the company to meet her evolving business needs. Miller said she joined Totus from Genentech. At Genentech, she was most recently Executive Director, responsible for Product Development Excellence, Portfolio, and Product Development Strategy. Prior to Genentech, Miller served as Senior Manager of Commercial/PDA and Business Development at Pfizer where she was WW.
“We are delighted to welcome Laura to the team at this important stage in the evolution of Totus as we enter clinical trials later this year and continue to grow the company,” said Dr. Dhawan. “Laura’s relevant wealth of experience and expertise will bring Tortoise one step closer to making the entire human genome druggable.”
This year, Totus Medicines plans to grow organically by hiring more than 50 new employees while expanding its TOS-358 drug program targeting the PI3Kα mutation that affects more than half a million people in the U.S. each year is. This mutation causes a significant proportion of breast, colon, lung, bladder, stomach and other cancers.
“Totus is in a period of rapid growth, and we are delighted to be a part of such an important period, from our internal expansion to our rapid transition into clinical trials.” Miller said“This is a once-in-a-lifetime opportunity for a talented and agile company, and I look forward to using my experience to help Tortoise reach its significant growth potential.”
About Tortoise Medicines
Founded in 2019, Totus Medicines uses breakthrough chemical biology to create life-changing therapies to treat previously untreatable diseases across the human genome.Totus’ base is Cambridge, Massachusetts.
For more information, see: totusmedicines.com follow tortoise LinkedIn When twitter.
SourceTotus Medicines
